Deepti Navaratna
Deepti Navaratna
Assistant Neuroscientist
Verified email at
Cited by
Cited by
Brain angiogenesis in developmental and pathological processes: neurovascular injury and angiogenic recovery after stroke
K Arai, G Jin, D Navaratna, EH Lo
The FEBS journal 276 (17), 4644-4652, 2009
Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes
D Navaratna, PG McGuire, G Menicucci, A Das
Diabetes 56 (9), 2380-2387, 2007
Mechanisms and targets for angiogenic therapy after stroke
D Navaratna, S Guo, K Arai, EH Lo
Cell adhesion & migration 3 (2), 216-223, 2009
Neurovascular matrix metalloproteinases and the blood-brain barrier
J Hae Seo, S Guo, J Lok, D Navaratna, M J Whalen, KW Kim, E H Lo
Current pharmaceutical design 18 (25), 3645-3648, 2012
Decreased cerebrovascular brain-derived neurotrophic factor–mediated neuroprotection in the diabetic brain
D Navaratna, S Guo, K Hayakawa, X Wang, C Gerhardinger, EH Lo
Diabetes 60 (6), 1789-1796, 2011
Pro-angiogenic effects of resveratrol in brain endothelial cells: nitric oxide-mediated regulation of vascular endothelial growth factor and metalloproteinases
F Simao, AS Pagnussat, JH Seo, D Navaratna, W Leung, J Lok, S Guo, ...
Journal of Cerebral Blood Flow & Metabolism 32 (5), 884-895, 2012
A peptide inhibitor of the urokinase/urokinase receptor system inhibits alteration of the blood-retinal barrier in diabetes
D Navaratna, G Menicucci, J Maestas, R Srinivasan, P McGuire, A Das
The FASEB Journal 22 (9), 3310, 2008
Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes
LC Wilsie, S Chanchani, D Navaratna, RA Orlando
Lipids in health and disease 4, 1-15, 2005
Neuregulin-1 effects on endothelial and blood–brain barrier permeability after experimental injury
J Lok, S Zhao, W Leung, JH Seo, D Navaratna, X Wang, MJ Whalen, ...
Translational stroke research 3, 119-124, 2012
Cerebrovascular degradation of TRKB by MMP9 in the diabetic brain
D Navaratna, X Fan, W Leung, J Lok, S Guo, C Xing, X Wang, EH Lo
The Journal of Clinical Investigation 123 (8), 3373-3377, 2013
Suppression of retinal neovascularization with an antagonist to vascular endothelial cadherin
D Navaratna, J Maestas, PG McGuire, A Das
Archives of Ophthalmology 126 (8), 1082-1088, 2008
How the heart whispers to the brain: serotonin as neurovascular mediator in patent foramen ovale related stroke
MM Ning, D Navaratna, Z Demirjian, I Inglessis-Azuaje, D McMullin, ...
Stroke 42 (3), E108-E109, 2011
Brain angiogenesis after stroke
K Hayakawa, JH Seo, N Miyamoto, LDD Pham, D Navaratna, EH Lo, ...
Biochemical Basis and Therapeutic Implications of Angiogenesis, 473-494, 2017
A peptide inhibitor of the uPA/uPAR system inhibits alteration of the blood-retinal barrier in diabetes
D Navaratna, G Menicucci, P McGuire, A Das
Investigative Ophthalmology & Visual Science 48 (13), 4025-4025, 2007
Beyond VEGF–other factors important in retinal neovascularization: Potential targets in proliferative diabetic retinopathy
A Das, D Navaratna, PG McGuire
Diabetic retinopathy, 375-398, 2008
Neurovascular responses to traumatic brain injury
J Lok, K Arai, S Guo, W Leung, T Maki, D Navaratna, K van Leyen, C Xing, ...
Vascular Mechanisms in CNS Trauma, 75-103, 2014
The Role of Matrix Metalloproteinases in Neurovascular Injury
JH Seo, S Guo, J Lok, D Navaratna, C Xing, EH Lo
Role of Proteases in Cellular Dysfunction, 93-102, 2014
Reduced brain-derived neurotrophic factor (BDNF) expression & secretion after treatment with advanced glycation endproducts in brain microvascular endothelial cells
I Karaca, D Navaratna, L Eng
VE-cadherin and vascular dysfunction in Diabetic Retinopathy
D Navaratna
The University of New Mexico, 2008
Urokinase and Its Receptor-A Novel Therapeutic Target in Diabetic Retinopathy.
D Navaratna, G Menicucci, P Mcguire, A Das
Diabetes 56, 2007
The system can't perform the operation now. Try again later.
Articles 1–20